|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Mycoplasma pneumoniae IgM ELISA | Anti-Cetuximab (Erbitux®) ELISA | Anti-Ustekinumab (Stelara®) ELISA | Insulin-like Growth Factor-Binding Protein-3 (IGFBP-3) ELISA | Prostate Specific Antigen (PSA) (Total) ELISA |
| Citations | | | | | |
| Catalog Number | IB79886 | TM09027 | TM09036 | E03A | IB19126 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Mycoplasma pneumoniae IgM ELISA is intended for the determination of IgM class antibodies against Mycoplasma pneumoniae in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Cetuximab (Erbitux®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme immunoassay (ELISA) for the determination of IGFBP-3 in human serum, plasma (heparin), or cerebrospinal fluid. For research use only, not for use in diagnostic procedures. | Solid phase enzyme immunoassay (ELISA) for the determination of PSA in human serum. For research use only, not for use in diagnostic procedures. |
| Detection Target | Vasopressin | sAPP Alpha | sAPP Total | Complement System Screen | Prostate Specific Antigen (PSA) |
| Sample Type | Blood Plasma, Urine | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 0 / 1 - 30 ng/mL | Anti-Ustekinumab (Stelara®) | 0.4 to 30.0 ng/mL | 0 / 2 - 50 ng/mL |
| Sensitivity | 0.5 pmol/L | 0.09 ng/mL | 0.06 ng/mL | Inquire | 0.0144 ng/mL |
| Assay Time | 1 hr, 45 mins (incubation) | 2 hours, 15 min. total incubation time. | 2 hour, 30 min. total incubation time. | 2 hrs 30 mins (incubation) | 1 hr 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |